Dr. Robert Stein, MD, PhD

Leader in AI powered Drug Development and Precision Medicine Superior Science and Risk-Sharing Business Models DYNAMIKA, Cloud AI-Powered Platform for Data Management Smart Imaging Strategy to Accelerate Drug Development
Bob-Stein_RD_135

Dr. Robert Stein, MD, PhD

Scientific Advisor
IAG’s Scientific Expert in preclinical development and translational medicine. Dr. Stein began his career at Merck, Sharp and Dohme. He holds an MD and a PhD in Physiology & Pharmacology from Duke University. Over his 30 years of experience in the biopharmaceutical industry he played a pivotal role in bringing to the market Sustiva®, Fablyn®, Viviant®, PanRetin®, TargRetin®, Promacta® and Eliquis®. Dr. Stein is helping our bio-pharmaceutical partners to shape clinical development strategy, discovery and optimization technology platforms and portfolio in oncology and immune-oncology programs.